There’s increasing awareness that our gut health isn’t just important when digesting food, but can also be a significant indicator of what’s happening in the rest of our body. If issues in the gut can act as early warning signs of wider health problems, then a gut health test is obviously a valuable investment. That explains why Viome Life Sciences has just secured millions in extra funding for its research (https://longevity.technology/news/viome-lands-86-5m-and-national-retail-deal-for-gut-health-test/).
Viome has been around since 2016. Its stated mission is to tackle the root causes of cancer and chronic disease, as well as aging generally. To do this, it has been studying the human microbiome. Modern technology and approaches, including the use of machine learning and AI, have allowed the analysis of more than 600,000 samples and the exploration of a broad range of microbial and human gene expressions.
This has allowed for the development of a wide selection of products, such as biotic blends and supplement formulas, that have been specially customized to support particular aspects of both gut and oral health across the incredible diversity of human individuality. One of its most notable recent announcements is the arrival of its Gut Intelligence health test in hundreds of CVS pharmacies across the US.
It wouldn’t be possible to launch a product like that without high demand. People are constantly looking for better ways to optimize their health and they’re realizing their gut is an important part of that. The Gut Intelligence test can provide you with a series of personalized recommendations designed to make your life not just longer but healthier, blocking aging and disease before they start.
All you need to do is send in a stool sample. A few weeks later, you’ll receive your results, with a score representing the current state of your gut health and suggestions on how you can modify your nutrition to best serve your overall well-being. It’s an acknowledgment that when it comes to health, there’s no such thing as a universal solution. Every person is different.
The gut health test is just one aspect of Viome’s current portfolio, adding to an expanding R&D department as well as a widening selection of retail products. Between the many investors attracted by Viome’s combination of AI-driven research and unique RNA technology, the recent round of investment has boosted the firm’s financial resources by about $175 million.
